Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Generic enzyme 10
[{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa17/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa17/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa16/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa16/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa15/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa15/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa14/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa14/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa13/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa13/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa12/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa12/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa11/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa11/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa10/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa10/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa0f/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa0f/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa0e/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa0e/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa0d/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa0d/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa0c/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa0c/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa0b/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa0b/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa0a/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa0a/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa09/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa09/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa08/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa08/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa07/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa07/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa06/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa06/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa05/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa05/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa04/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa04/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa03/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa03/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa02/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa02/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa01/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa01/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4fa00/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4fa00/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9ff/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9ff/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9fe/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9fe/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9fd/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9fd/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9fc/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9fc/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9fb/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9fb/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9fa/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9fa/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9f9/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9f9/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9f8/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9f8/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9f7/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9f7/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9f6/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9f6/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9f5/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9f5/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9f4/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9f4/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9f3/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9f3/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9f2/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9f2/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9f1/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9f1/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9f0/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9f0/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9ef/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9ef/5d2ce3b8f02f730400c4f9ed.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3fdf02f730400c4f9ee/5d2ce3b8f02f730400c4f9ed.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3fdf02f730400c4f9ee/5d2ce3b8f02f730400c4f9ed.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
receptor,ligand,target ligand,targeting ligand,targeted ligand,protein,pathway,signaling,cascade,diagram,transcription factor,generic,catalyst,enzyme,substrate,lock and key
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
